Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
People channel feed
Sean Bohen's break from biopharma is over. The ex-AstraZeneca CMO has retired his Big Pharma jersey and is now — happily — running a little biotech
5 years ago
Bioregnum
Opinion
After leading Celgene buyout, Matthew Roden leaves Bristol Myers Squibb for venture capital firm
5 years ago
Ex-Allergan CMO takes the helm at Lewis Cantley's metastasis-focused biotech startup
5 years ago
Cygnal's Pearl Huang recruits former Merck colleague John Wagner to realize broad exoneural vision in the clinic
5 years ago
Ex-Moderna CFO Lorence Kim joins a new class of venture partners jumping on board Third Rock
5 years ago
Following job cuts and R&D restructuring, microcap microRNA player miRagen brings in new CEO to right the ship
5 years ago
Scoop: Gilead’s CAR-T player Kite waves goodbye to research chief Peter Emtage as another top exec hits the exit
5 years ago
Cell/Gene Tx
Savara's long-reigning duo both resign in the wake of CF bust
5 years ago
$1.6 billion liquid biopsy player Grail files IPO, revealing 2021 commercial plans and a Midas-sized $65M pay package for Hans Bishop
5 years ago
Financing
Longtime biotech vet Andrew Hirsch is taking the top job at C4 — and he clearly has some big plans
5 years ago
R&D
Another Big Pharma 'lifer' in the top ranks of R&D is starting a new chapter in biotech
5 years ago
R&D
FDA commissioner Hahn ousts agency’s new chief spokesperson as plasma controversy continues to smolder
5 years ago
Coronavirus
A small VC group expands its hunt for inspired biotech founders in need of seed cash
5 years ago
Financing
Troy Wilson recruits AstraZeneca vet to steer Kura's late-stage pivot
5 years ago
Driving to the $278M mark on raises, a legendary R&D expert sets his sights on another pivotal goal line
5 years ago
Financing
Startups
ROME founder Rosana Kapeller recruits a CSO from the senior ranks of a major league R&D team
5 years ago
Federal judge denies Martin Shkreli all but one motion to dismiss monopoly claims in the FTC's Daraprim lawsuit
5 years ago
Pharma
Sorrento ousts CFO as long-running Covid-19 drama continues
5 years ago
Coronavirus
Martin Shkreli continued to orchestrate anti-competitive schemes for Daraprim behind bars — FTC
5 years ago
Pharma
Spark Therapeutics nabs new CMO from Genentech, filling a major post-merger departure
5 years ago
Alnylam president Barry Greene leaves after 17 years, handing position over to Yvonne Greenstreet as biotech looks toward profitability
5 years ago
CureVac nabs a top Novartis scientist for CSO slot as mRNA vaccines seize the spotlight
5 years ago
Rich Heyman joins PMV Pharma, a p53 biotech, as it adds $70 million in Series D
5 years ago
Financing
CAR-T filing in sight, Frank Zhang grabs full control of J&J-partnered Legend Biotech, steps down from GenScript
5 years ago
China
First page
Previous page
66
67
68
69
70
71
72
Next page
Last page